Intermittent treatment of recurrent type-1 gastric carcinoids with somatostatin analogues in patients with chronic autoimmune atrophic gastritis
- 1 November 2015
- journal article
- research article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 47 (11) , 978-983
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Review article: the investigation and management of gastric neuroendocrine tumoursAlimentary Pharmacology & Therapeutics, 2014
- Management and clinical outcomes of type I gastric carcinoid patients: Retrospective, multicenter study in JapanDigestive Endoscopy, 2013
- Gastric Carcinoids (Neuroendocrine Neoplasms)Gastroenterology Clinics of North America, 2013
- Current Concepts on Gastric Carcinoid TumorsGastroenterology Research and Practice, 2012
- ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal NeoplasmsNeuroendocrinology, 2012
- The Epidemiology of Gastroenteropancreatic Neuroendocrine TumorsEndocrinology and Metabolism Clinics of North America, 2011
- Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parametersEndocrine-Related Cancer, 2010
- Carcinoid Tumors of the Gastrointestinal Tract: Trends in Incidence in England Since 1971American Journal of Gastroenterology, 2010
- Long-term follow up of patients with multiple gastric carcinoids associated with type A gastritisGastric Cancer, 2005
- A 50-Year Analysis of 562 Gastric Carcinoids: Small Tumor or Larger Problem?American Journal of Gastroenterology, 2004